Emerging research suggest Retatrutide , a dual agonist targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , appears to represent a promising advancement for obesity loss . https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026